Alaunos Therapeutics, Inc. (TCRT)
NCM · Healthcare · Biotechnology
$1.90
+0.00%
Closing price as of 2026-07-29 · Source: TEK2day Finance
Key Metrics
Market Cap
$4.6M
Shares Outstanding
2.4M
P/S (TTM)
1,547x
Exchange
NCM
Currency
USD
About Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 3K | 0.00 |
| Operating Income | -1.0M | -1.2M | -907K | -1.0M |
| Net Income | -1.1M | -1.2M | -893K | -1.0M |
| Diluted EPS | $-0.63 | $-0.55 | $nan | $-0.59 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 2.9M | 5K | 10K | 5K |
| Operating Income | -35.2M | -28.5M | -4.8M | -4.2M |
| Net Income | -37.7M | -35.1M | -4.7M | -4.2M |
| Diluted EPS | $-25.50 | $-21.97 | $-2.92 | $-2.20 |